Clinical Trials List
Protocol NumberVGFTe-ROP-1920
Completed
2021-04-13 - 2022-03-08
Phase III
Terminated3
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 江明洲 Division of Ophthalmology
- 孫銘輝 Division of Ophthalmology
- 傅仁煇 Division of Ophthalmology
- 朱世明 Division of Ophthalmology
- 林瑞瑩 Division of Ophthalmology
- 陳彥伯 Division of Ophthalmology
- Jen Fu Hsu Division of Ophthalmology
- Yih-Shiou Hwang Division of Ophthalmology
- 周宏達 Division of Ophthalmology
- 陳冠任 Division of Ophthalmology
- Chun-Hsiu Liu Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsiu-Lin Chen Division of Ophthalmology
- Li-chung Chi Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
127 participants
